Advances in Pharmacology and Therapeutics Journal

Advances in Pharmacology and Therapeutics Journal

Semi-Industrial Microwave-Assisted Extraction of an Alizarin-Rich Extract from Rubia tinctorum Roots: Process Development and UV–Vis/HPLC Characterization

Document Type : Original Article

Authors
1 Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran
2 Royan Technology Padideh Pardis Company, Yazd, Iran
3 M.Sc. student, Department of Business Management, Yazd Branch, Islamic Azad University, Yazd, Iran
4 Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), P.O.Box: 14395-836, Tehran, Iran
5 Department of General Surgery, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
Abstract
Abstract
Introduction: This study evaluates a semi-industrial microwave-assisted extraction (MAE) system for recovering an alizarin-rich extract from Rubia tinctorum roots.
Methods: A semi-industrial microwave extractor (IRAD-MEEO-140109) was used with ethanol/water (3:7 v/v). To minimize thermal degradation risk, controlled irradiation cycles and temperature (up to 60 °C) were applied. Optical properties were evaluated by UV–Vis, and relative purity was assessed by HPLC-UV against a Merck standard.
Results: The extraction showed good reproducibility (n = 3, RSD < 10% for yield and peak height). From 400 g of plant material, 76 g of dried extract was obtained (yield 19% w/w). Alizarin content and absolute recovery were not determined. UV–Vis measurements were performed once per concentration (n = 1), while extraction and HPLC were triplicate (n = 3). UV–Vis showed peaks at ~330 and 420 nm. HPLC showed a major peak assigned to alizarin (tR = 2.9 min) with ~75% relative chromatographic area purity. Total energy consumption was estimated at 0.48 kWh (1.2 kWh/kg). A theoretical comparison with reflux extraction suggests lower energy demand; however, this is approximate and not experimentally validated.
Conclusion: This study provides a process development framework for semi-industrial MAE of alizarin, serving as a basis for future studies rather than a demonstration of therapeutic or industrial applicability.
Keywords
Subjects


Articles in Press, Accepted Manuscript
Available Online from 21 November 2026